Resonate Blends, Inc.

KOAN

US76090M1027

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:30:09 2024-05-13 am EDT			5-day change	1st Jan Change
0.039 ^USD	+30.00%		+55.38%	+251.35%

Apr. 16	Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 20	Resonate Blends, Inc. Announces Executive Changes	CI

Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

April 16, 2024 at 05:25 pm EDT

Resonate Blends, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.016468 million compared to USD 0.049501 million a year ago. Net loss was USD 1.42 million compared to net income of USD 0.653627 million a year ago.

Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.

Latest news about Resonate Blends, Inc.

Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Resonate Blends, Inc. Announces Executive Changes	Mar. 20	CI
Resonate Blends, Inc. cancelled the acquisition of Pegasus Specialty Vehicles, LLC.	Dec. 06	CI
Resonate Blends, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Resonate Blends, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Resonate Blends, Inc. announced that it has received $0.05 million in funding	23-08-08	CI
Resonate Blends, Inc. announced that it has received $0.25 million in funding	23-07-31	CI
Resonate Blends, Inc. announced that it has received $0.48875 million in funding	23-06-19	CI
Resonate Blends, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Resonate Blends, Inc. signed a non-binding letter of intent to acquire Pegasus Specialty Vehicles, LLC for $3.5 million.	23-05-21	CI
Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Resonate Blends, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
Resonate Blends, Inc. cancelled the acquisition of Iron Summit Distribution, Inc.	23-04-16	CI
Resonate Blends Announces Koan Cordials Now Available At the Woods	23-02-02	CI
Resonate Blends, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Resonate Blends Officially Launches Its Anticipated “Sleep” Cordial to California Consumers	22-09-29	CI
Resonate Blends, Inc. entered into an agreement to acquire Iron Summit Distribution, Inc.	22-09-19	CI
Resonate Blends, Inc. announced that it has received $0.6 million in funding from AJB Capital Investments LLC	22-09-12	CI
Resonate Blends, Inc. announced that it expects to receive $0.6 million in funding from AJB Capital Investments LLC	22-09-07	CI
Resonate Blends, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
Resonate Blends, Inc. announced that it has received $0.1285 million in funding from 1800 Diagonal Lending, LLC	22-06-26	CI
Resonate Blends, Inc. Partners with Nabis	22-05-26	CI
Resonate Blends, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-20	CI
Resonate Blends, Inc. Auditor Raises 'Going Concern' Doubt	22-04-18	CI
Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI

Chart Resonate Blends, Inc.

Duration

Period

More charts

Company Profile

Resonate Blends, Inc. is a cannabis holding company. The Company, through its subsidiary, Resonate Blends LLC, offers wellness and lifestyle brands, which are built on a system of experiential targets. The Companyâs products include Calm, Wonder, Love, Create, Play, Delight and Sleep. Its products are emulsified, water-soluble, single-dose formulas that can be used privately or shared socially. These products can be taken directly from the bottle or poured into beverages. Its Calm product consists of Cannabidiol (CBD) along with Tetrahydrocannabinol (THC). Its Wonder product consists of THC. Its Create product is formulated with a blend of terpenes and THC. Its Play product helps people to become fully immersed in the moment and the people around them. The Company also operates an intellectual property (IP) subsidiary, namely Entourage Labs LLC.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
RESONATE BLENDS, INC.	+251.35%	3.75M
DONG-E-E-JIAO CO.,LTD.	+44.36%	6.29B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-13.52%	4.55B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.85%	3.27B
TASLY PHARMACEUTICAL GROUP CO., LTD	-6.52%	3.23B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.71%	2.56B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+51.14%	2B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.22%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+1.29%	1.64B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+57.69%	1.6B

Alternative Medicine